Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that impacts motor neurons, leading to muscle weakness and paralysis. Despite significant research, treatment options for ALS remain limited. However, emerging therapies are poised to change the treatment landscape, offering hope for better outcomes, especially for early-stage ALS patients. Advances in FDA-Approved...